Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Machine learning system to assist in robot-assisted surgery for rectal cancer

Official title: Machine Learning-based Surgical Guidance System for Robot-assisted Rectal Surgery - a First-in-human Interventional Study

Run by Technische Universität Dresden · NCT05652361 · Data updated 2026-11-12

This study is testing a new machine learning system to see if it can help surgeons perform robot-assisted surgery for rectal cancer more accurately and improve patient outcomes.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment12 (estimated)
SponsorTechnische Universität Dresden
Academic / other
Locations1 site (Dresden, Saxony)
StatusRecruiting
StartedFebruary 25, 2026
Main results expectedJanuary 2027
Study endsDecember 2027
Registry record updatedAugust 27, 2026
Trial IDNCT05652361 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients with rectal cancer who are scheduled for robot-assisted rectal resection and have intact preoperative urogenital and rectal function.

Probably not a fit

Patients with a history of other malignant diseases within the last five years or those who have had significant prior abdominal surgeries may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates a surgical guidance system that utilizes machine learning and image recognition algorithms to assist surgeons during robot-assisted rectal surgery. It aims to assess the technical feasibility and applicability of this innovative approach in a first-in-human pilot study. Additionally, the study will gather preliminary data on the oncological outcomes associated with the use of this surgical assistance system. The intervention involves enhanced visualization during surgery to potentially improve surgical precision and patient outcomes.

Why it matters

Potential benefit: If successful, this system could enhance surgical precision and improve outcomes for patients undergoing rectal cancer surgery.

How similar studies have gone: While the use of machine learning in surgical assistance is a growing field, this specific application in robot-assisted rectal surgery is novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with rectal cancer scheduled for robot-assisted rectal resection
* Intact preoperative urogenital/rectal function
* Full capability of consent

Exclusion Criteria:

* Previous/Second malignant disease \<5 years before diagnosis of rectal cancer
* Previous abdominal surgery, except for laparoscopic appendectomy, laparoscopic cholecystectomy or Cesarean section
* Pregnant or breastfeeding women
* Addiction or illness that prevent the person concerned from assessing the nature and scope of the clinical trial and its possible consequences
* indication that the participant is unlikely to comply with the trial protocoll (e.g. lack of compliance)
* official or court order for involuntary hospitalization

Where it's running

  • Department of Visceral, Thoracic and Vascular Surgery University Hospital Carl Gustav Carus Technische Universität Dresden
    Dresden, Saxony, Germany
    Recruiting

Study contacts

  • Principal investigator: Marius Distler, Prof. Dr. — University Hospital Carl Gustav Carus Dresden
  • Study coordinator: Marius Distler, Prof. Dr.
  • Email: marius.distler@ukdd.de
  • Phone: +49 351 458 4098

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Neoadjuvant treatment for locally advanced rectal cancer

    This study is testing a new chemotherapy treatment for people with locally advanced rectal cancer to see if it works better than the standard treatment before surgery.

    Recruiting Phase 2 Menoufia University · Shibīn al Kawm, Menoufia · NCT06812728

  • Using augmented reality to assist in rectal cancer surgery

    This study is testing if using augmented reality during rectal cancer surgery can help doctors see better and perform the surgery more effectively.

    Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna · NCT06805045

  • Imaging method for digestive system cancer using targeted PET scans

    This study is testing a new type of PET scan to see if it can better help doctors find and diagnose cancers in the digestive system.

    Recruiting RenJi Hospital · Shanghai, Shanghai Municipality · NCT06715839

  • Treatment for advanced colon and rectal cancer using immune cells

    This study is testing a new treatment that uses the patient's own immune cells combined with other medications to see if it can help people with advanced colon and rectal cancer feel better and live longer.

    Recruiting Phase 1/2 Essen Biotech · Beijing, Beijing Municipality · NCT06530303

  • Adaptive radiotherapy using a new linear accelerator for cancer treatment

    This study is testing a new way to adjust radiation therapy for cancer patients each day based on changes in their tumors to see if it improves treatment.

    Recruiting Charite University, Berlin, Germany · Berlin · NCT06116019

  • Improving care for rural patients with solid tumors

    This study is testing a new support program to see if it helps rural patients with solid tumors start and finish their treatment faster compared to usual care.

    Recruiting at 14 sites University of Colorado, Denver · Aurora, Colorado and 13 other locations · NCT04916990

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.